Claris Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$7.69K 83
2024
Q3
$7.69K Buy
+500
New +$7.69K ﹤0.01% 242